Qualitative and quantitative effects of APOE genetic variation on plasma C-reactive protein, LDL-cholesterol, and apoE protein

Genes and Immunity
D I ChasmanP M Ridker

Abstract

A genetic link between lipid metabolism and inflammation has been suggested by the association between variation in the APOE gene and plasma C-reactive protein (CRP). This association was confirmed among Caucasians and extended to an African-American population, and the well-known associations of APOE variation with LDL-C and apoE protein were also observed. While eight common variants in APOE were examined, the association with CRP involved primarily the two nonsynonymous SNPs that define the major epsilon2, epsilon3, and epsilon4 alleles. In particular, the strongest link involved lower CRP levels among carriers of the APOE epsilon4 allele that also contributes to the risk of cardiovascular and Alzheimer's diseases as well as to higher lipid levels. A lesser effect was characterized by lower CRP levels among carriers of a subtype of the epsilon3 allele. The magnitude of the association with plasma CRP was at least as great as the effect of variation in the CRP gene itself. Quantitative analysis suggested that the effect on CRP is more likely a consequence of intrinsic functional differences among the E2, E3, and E4 apoE proteins than different levels of apoE protein or LDL-C in the plasma.

References

Jan 1, 1988·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·J DavignonC F Sing
Mar 1, 1985·Preventive Medicine·C H Hennekens, K Eberlein
Sep 18, 1993·Lancet·J PoirierS Gauthier
Jan 1, 1994·Advances in Protein Chemistry·K H Weisgraber
Apr 3, 1997·The New England Journal of Medicine·P M RidkerC H Hennekens
Jul 4, 2001·JAMA : the Journal of the American Medical Association·M A AlbertUNKNOWN PRINCE Investigators
Nov 10, 2001·Annual Review of Genomics and Human Genetics·R W Mahley, S C Rall
Jan 10, 2002·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·K Bach-NgohouJ M Bard
Jan 16, 2002·American Journal of Human Genetics·Daniel J SchaidGregory A Poland
Oct 24, 2003·American Journal of Human Genetics·Matthew Stephens, Peter Donnelly
Jan 20, 2004·Journal of Medical Genetics·C AucanA V S Hill
Jun 17, 2004·JAMA : the Journal of the American Medical Association·Daniel I ChasmanPaul M Ridker
Jul 21, 2004·Annals of Internal Medicine·Yiqing SongSimin Liu
Mar 9, 2005·The New England Journal of Medicine·Paul M RidkerJulie E Buring
May 18, 2005·American Journal of Human Genetics·Christopher S CarlsonAlexander P Reiner
May 28, 2005·Proceedings of the National Academy of Sciences of the United States of America·Gideon M HirschfieldMark B Pepys
Jul 7, 2005·JAMA : the Journal of the American Medical Association·Nancy R CookJulie E Buring
Jul 7, 2005·JAMA : the Journal of the American Medical Association·I-Min LeeJulie E Buring
Nov 3, 2005·Nature Clinical Practice. Cardiovascular Medicine·Subodh VermaPaul M Ridker
Nov 4, 2005·Annals of Human Genetics·D T MillerD J Kwiatkowski

❮ Previous
Next ❯

Citations

Nov 17, 2009·Archives of Dermatological Research·Pablo Coto-SeguraJorge Santos-Juanes
Nov 6, 2009·European Journal of Epidemiology·Gabriella AndreottiAnn W Hsing
Feb 27, 2013·Neurodegenerative Disease Management·Andrea L Metti, Jane A Cauley
Apr 11, 2014·Genetic Epidemiology·Jacklyn N HellwegeDonald W Bowden
Jan 9, 2008·Journal of the American Geriatrics Society·Alexander M KulminskiAnatoli I Yashin
Apr 1, 2016·Nature Communications·Peter K JoshiJames F Wilson
Jun 29, 2010·Journal of the American College of Cardiology·Christopher Newton-Cheh, J Gustav Smith
Sep 26, 2013·Experimental Gerontology·Igor AkushevichAnatoliy I Yashin
Apr 29, 2008·American Journal of Human Genetics·Alexander P ReinerRonald M Krauss
Sep 5, 2014·Human Molecular Genetics·Ursula M SchickUNKNOWN National Heart, Lung, and Blood Institute GO Exome Sequencing Project
Jul 8, 2017·PloS One·Morten Krogh ChristiansenSteen Dalby Kristensen
Nov 26, 2008·Clinical Chemistry·Daniel I ChasmanPaul M Ridker
May 2, 2014·Disease Markers·Fahad Al HarthiAbdulrahaman Al-Asmari
Jul 11, 2020·BMC Medical Genetics·Per G FarupKnut Hestad
Oct 26, 2018·Circulation Research·Cristina GiulianiClaudio Franceschi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.